Skip to main content
JOHNSON & JOHNSON logo

JOHNSON & JOHNSON — Investor Relations & Filings

Ticker · JNJ ISIN · US4781601046 LEI · 549300G0CFPGEF6X2043 US Manufacturing
Open in API
Filings indexed 3,142 across all filing types
Latest filing 2008-12-03 Director's Dealing
Country US United States of America
Listing US JNJ

About JOHNSON & JOHNSON

https://www.jnj.com/

Johnson & Johnson is a healthcare company that operates through two primary segments: Innovative Medicine and MedTech. The Innovative Medicine division is focused on the research, development, and delivery of new treatments for complex diseases in areas such as oncology, immunology, neuroscience, and cardiopulmonary conditions. The MedTech segment develops and provides a broad portfolio of medical technologies and solutions. It innovates in fields including surgery, orthopaedics, vision, and interventional solutions, aiming to create smarter, less invasive, and more personalized healthcare treatments. The company's mission is to address significant health challenges through science-based innovation at the intersection of biology and technology.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2008-12-03 English
PRIMARY DOCUMENT
Director's Dealing
2008-12-01 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated November 24, 2008. It references the Registrant's Quarterly Report on Form 10-Q for the fiscal quarter ended September 28, 2008, but the document itself is a current report attaching XBRL documents related to that 10-Q. The text explicitly states that the XBRL documents are unaudited and not the official financial statements, and the purpose is to test the format and technology. The document is short (4131 characters) and primarily serves as an announcement and submission of supplemental XBRL data, not the financial report itself. According to the "Menu vs Meal" rule, this is an announcement-type filing rather than the actual quarterly report. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous filings that do not fit other categories and includes such current reports and certifications.
2008-11-24 English
PRIMARY DOCUMENT
Director's Dealing
2008-11-13 English
Interim / Quarterly Report 2008
Interim / Quarterly Report 9M 2008
2008-11-04 English
PRIMARY DOCUMENT
Director's Dealing
2008-10-31 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.